BioRegenx (BRGX) Financial Statements
BioRegenx Financial Overview
BioRegenx's market cap is currently $194.31K. The company's EPS TTM is $-0.00; its P/E ratio is -0.15; BioRegenx has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.85M | $ 2.34M | $ 22.24K | $ 42.16K | $ 198.58K |
| Gross Profit | $ 1.50M | $ 1.66M | $ 16.31K | $ 36.23K | $ 198.03K |
| Operating Income | $ -518.99K | $ -22.76M | $ -110.00K | $ -78.31K | $ -165.00K |
| EBITDA | $ -443.92K | $ -22.76M | $ -558.23K | $ -72.38K | $ -161.00K |
| Net Income | $ -1.54M | $ -23.05M | $ -571.00K | $ -78.31K | $ -96.87K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 69.38K | $ 58.40K | $ 125.40K | $ 676.00 | $ 24.36K |
| Total Assets | $ 410.99K | $ 508.54K | $ 31.64K | $ 59.15K | $ 127.76K |
| Total Debt | $ 2.21M | $ 2.16M | $ 225.37K | $ 240.97K | $ 200.00K |
| Net Debt | $ 2.15M | $ 2.11M | $ 225.37K | $ 240.29K | $ 175.64K |
| Total Liabilities | $ 4.95M | $ 3.89M | $ 253.61K | $ 260.69K | $ 212.00K |
| Stockholders' Equity | $ -4.54M | $ -3.38M | $ -221.97K | $ -201.54K | $ -84.23K |
| Cash Flow | |||||
| Free Cash Flow | $ 29.91K | $ -513.54K | $ -13.35K | $ -64.65K | $ -151.06K |
| Operating Cash Flow | $ 38.97K | $ -324.15K | $ -13.35K | $ -64.65K | $ -119.52K |
| Investing Cash Flow | $ -59.06K | $ -187.94K | $ 0.00 | $ 0.00 | $ -31.55K |
| Financing Cash Flow | $ 33.10K | $ 442.12K | $ 12.67K | $ 40.97K | $ 50.00K |
Currency in USD
